RxDoctor Payments Data

Viliami Vakautakakala, DPM

Foot & Ankle Surgery · Richfield, UTNPI 1457768160

Payments from drug & device makers

What this record shows

Stryker accounts for 72.5% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $4,485 and has fallen 87.7% since, to $552 in 2025.

$8,155in general payments, 2019–2025

Across 200 payments — averaging $40.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$6K
  • Treace Medical Concepts, Inc.$754
  • Paragon 28, Inc.$666
  • Amgen$225
  • ANI Pharmaceuticals, Inc.$179
  • Organogenesis Inc.$93
  • plus $324 from 8 others

What the payments were for

  • Travel & lodging$3,63345%
  • Food & beverage$4,52255%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,155 in reported general payments places this provider in the 75th percentile of 104 foot & ankle surgery providers in Utah.

See all foot & ankle surgery providers in Utah

Medicare billing

Part B allowed, 2024
$274,151
Medicare patients
438
Services billed
3,640

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin179$1,895
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen50$483
Celecoxib17$458
Methylprednisolone53$425
Gabapentin28$417
Doxycycline Hyclate34$309
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav18$170
Colchicine13$135
Allopurinol12$116
Naproxen19$111
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim15$110
Promethazine Hcl14$48

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Richfield

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →